O21.2 One Profile or Many? Plasma Biomarkers Cxcl10, Scd163 and Scd14 Reveal Distinct Associations With Hiv Treatment Response, Choice of Treatment Regimen, and Cardiovascular Risk Factors

Sexually Transmitted Infections - United Kingdom
doi 10.1136/sextrans-2015-052270.194
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Persistent High Plasma Levels of sCD163 and sCD14 in Adult Patients With Measles Virus Infection

PLoS ONE
Multidisciplinary
2018English

Ad1 - Association of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis

JAMA - Journal of the American Medical Association
Medicine
2006English

Reasons and Risk Factors for the Initial Regimen Modification in Chinese Treatment-Naïve Patients With HIV Infection: A Retrospective Cohort Analysis

PLoS ONE
Multidisciplinary
2015English

Cardiovascular Co-Morbidity in Patients With Rheumatoid Arthritis: A Narrative Review of Risk Factors, Cardiovascular Risk Assessment and Treatment

BMC Rheumatology
Rheumatology
2018English

Profile of Cardiovascular Risk Factors in Nigerians With Stroke

World Journal of Cardiovascular Surgery
2016English

Nontraditional Cardiovascular Biomarkers and Risk Factors: Rationale and Future Perspectives

Biomolecules
BiochemistryMolecular Biology
2018English

Genetic Polymorphisms in Aquaporin 1 as Risk Factors for Malignant Mesothelioma and Biomarkers of Response to Cisplatin Treatment

Radiology and Oncology
Nuclear MedicineRadiologyImagingOncology
2019English

Associations of Cardiovascular Disease Risk Factors and Calcified Atherosclerosis With Aortoiliac Bifurcation Position

Angiology
Cardiovascular MedicineCardiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy